The different types of OTUB1 have different degrees of cytotoxicity, suggesting that the production of a molecule that can inhibit the formation of OTUB1 oligomers and fibrils could have therapeutic effects in PD cases where OTUB1 expression is altered. Here, OTUB1 is linked to Parkinson disease.